An overview of our key therapeutic areas
Teva is committed to delivering medicines to meet the needs of patients and families affected by disorders of the Central Nervous System (CNS).
A global leader in treatments for disorders of the central nervous system (CNS), Teva provides products to treat patients with neurological and neurodegenerative disorders, pain, and sleep disorders, in countries around the world.
Teva is also developing innovative solutions in headache and migraine, and socially responsible pain treatments.
Teva is committed to providing high-quality treatments for people who suffer from respiratory diseases, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD). Our innovative approach to respiratory care is centered on optimizing therapies through novel delivery systems and medicines that are designed to address patient needs.
Teva is focused on developing and providing treatment options that address two major issues within the current treatment landscape for respiratory diseases: 1) treatment adherence and compliance and 2) treating asthma that remains uncontrolled despite the use of a standard of care therapy.
In the treatment of asthma, the goal is to maintain asthma control so people with asthma can maintain good lung function, exhibit fewer symptoms and experience fewer asthma attacks.
Teva delivers a range of respiratory medicines today, including controller and rescue therapy. We are also committed to the development of new treatment options. Teva’s focus is on combining our integrated strengths in specialty medicines (including both small molecules and biologics), device platforms and generics.
In addition to our currently available medicines, Teva has a broad pipeline of treatment options currently in development with the goal of further enhancing our product offerings and addressing unmet needs within the respiratory community.
In Oncology, we are making a profound difference in the lives of patients with cancer. We supply a variety of therapies, including treatment for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma. Teva also markets several biologic medications which form a part of the treatment regimen for oncology patients.
Teva offers effective solutions for the treatment of pain in opioid-tolerant adult patients with cancer, for the relief of muscle spasm in musculoskeletal conditions and for the acute treatment of pain and nausea in adults who suffer from migraine headaches.
Teva’s over-the-counter (OTC) products include a range of consumer healthcare treatments available without a prescription that help to heal, relieve and prevent a variety of conditions.
Our experience in markets with significantly different customer cultures and needs gives us the agility for timely delivery of the relevant products and quantities. With a global presence, timely, reliable and cost-effective distribution is critical to our customers’ ability to provide their end consumers with safe and effective products at the right time.